Literature DB >> 10085624

Idiopathic central serous chorioretinopathy.

D Hussain1, J D Gass.   

Abstract

Idiopathic central serous chorioretinopathy (ICSC) is usually seen in young males with Type A personality. Clinical evaluation of the macula with fundoscopy and biomicroscopy, coupled with fluorescein angiography establishes the diagnosis. Indocyanine green angiographic studies have reinformed that the basic pathology lies in choriocapillaries and retinal pigment epithelium. Most of the ICSC resolve completely in four months, and some of them could resolve early with direct photocoagulation of the leaking site. Oral steroids have no role, and could even cause an adverse reaction.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10085624

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


  19 in total

1.  Effects of photodynamic therapy with verteporfin for the treatment of chronic central serous chorioretinopathy: An uncontrolled, open-label, observational study.

Authors:  Yildirim Bayezit Sakalar; Ugur Keklikci; Kaan Unlu; Mehmet Fuat Alakus; Ismail Hamdi Kara
Journal:  Curr Ther Res Clin Exp       Date:  2010-06

Review 2.  Lack of positive effect of intravitreal bevacizumab in central serous chorioretinopathy: meta-analysis and review.

Authors:  Y-R Chung; E J Seo; H M Lew; K H Lee
Journal:  Eye (Lond)       Date:  2013-11-08       Impact factor: 3.775

3.  Transpupillary thermotherapy for chronic central serous chorioretinopathy.

Authors:  Nazimul Hussain; Rohit Khanna; Anjli Hussain; Taraprasad Das
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-01-13       Impact factor: 3.117

4.  The relationship between the central serous chorioretinopathy, choroidal thickness, and serum hormone levels.

Authors:  Emine Çiloğlu; Fikret Unal; Nese Cetin Dogan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-04-18       Impact factor: 3.117

5.  Serum cortisol and testosterone levels in chronic central serous chorioretinopathy.

Authors:  Hasan Ali Tufan; Baran Gencer; Arzu Taskiran Comez
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-06-21       Impact factor: 3.117

6.  Photodynamic therapy with verteporfin for chronic central serous choroidoretinopathy and idiopathic choroidal neovascularization-first report from the sultanate of oman.

Authors:  Upender Krishen Wali; Nadia Al-Kharousi; Harith Hamood
Journal:  Oman Med J       Date:  2008-10

7.  The efficacy of intravitreal bevacizumab for idiopathic central serous chorioretinopathy.

Authors:  Ji Won Lim; Min Uk Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-12-08       Impact factor: 3.117

8.  Obstructive sleep apnea in patients with central serous chorioretinopathy.

Authors:  Patrik Kloos; Irene Laube; Adelheid Thoelen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-06-11       Impact factor: 3.117

9.  [Intraocular injections of bevacizumab in rare indications--two cases].

Authors:  T Wecke; C Knop; W Schreiber; W Behrens-Baumann
Journal:  Ophthalmologe       Date:  2009-05       Impact factor: 1.059

10.  Comparison of Serum Cortisol and Testosterone Levels in Acute and Chronic Central Serous Chorioretinopathy.

Authors:  Tanie Natung; Avonuo Keditsu
Journal:  Korean J Ophthalmol       Date:  2015-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.